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Abstract: 
Human saliva is a biological fluid with enormous diagnostic potential. Because saliva can be non-invasively collected, it provides an attractive alternative 
for blood, serum or plasma. It has been postulated that the blood concentrations of many components are reflected in saliva. Saliva harbors a wide array of 
proteins, which can be informative for the detection of diseases. Profiling the proteins in saliva over the course of disease progression could reveal 
potential biomarkers indicative of different stages of diseases, which may be useful in medical diagnostics. With advanced instrumentation and developed 
refined analytical techniques, proteomics is widely envisioned as a useful and powerful approach for salivary proteomic biomarker discovery. As 
proteomic technologies continue to mature, salivary proteomics have great potential for biomarker research and clinical applications. The progress and 
current status of salivary proteomics and its application in the biomarker discovery of oral and systematic diseases will be reviewed. The scientific and 
clinical challenges underlying this approach will also be discussed. 
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Background: 
Human saliva is secreted from three pairs of major salivary glands namely 
parotid gland, submandibular gland and sublingual gland lying at the 
vicinity of oral cavity, and numerous minor salivary glands lying beneath 
the oral mucosa. It contains a large array of proteins, many of which can be 
informative for the detection of oral and systemic diseases. Saliva is an 
attractive diagnostic fluid because it has several key advantages for disease 
diagnosis and prognosis, for example low invasiveness, minimum cost, and 
easy sample collection and processing [1].  
 
Relaying on the significant advances in mass spectrometry technologies, 
proteomics is widely envisioned as a useful and powerful approach for 
proteome research. Of particular note is the salivary proteomic biomarker 
discovery and validation, which involved high throughput proteomic 
approaches [1, 2]. Recently, salivary proteomics has demonstrated a great 
potential for biomarker discovery and validation for various oral and 
systemic diseases. In this review, the progress and prospects of salivary 
proteomics and its implications in oral and systematic diseases will be 
reviewed. In addition, the scientific and clinical challenges pertaining to 
the approach will be discussed. 
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Salivary Proteomics: 
Different proteomic technologies have been used to analyze the protein 
composition of saliva qualitatively and quantitatively. Based on advanced 
mass spectrometry technologies, the capability of saliva protein 
identification has been greatly enhanced by combining different protein 
separation technologies. As for example, free-flow electrophoresis has 
been coupled with linear ion-trap tandem mass spectrometry to identify 
salivary proteins. Multidimensional separation platform based on capillary 
isoelectric focusing and nano-reversed phase liquid chromatography has 
also been successfully utilized for salivary protein separation. Two 
dimensional gel electrophoresis (2-DE) coupled with matrix-assisted laser 
desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) 
or liquid chromatography-mass spectrometry (LC-MS/MS) has been used 
as a routine approach for salivary protein separation, quantitation and 
identification [3]. Besides, non-gel based labeling methods such as iTRAQ 
[isobaric tag for relative and absolute quantitation] and label-free 
quantitation have been used for quantitative salivary proteome analysis. 
According to a recent consortium study, 1,166 proteins were identified in 
saliva (914 from the parotid fluid and 917 from the combined 
submandibular and sublingual fluids) and a high portion of these proteins 
was also found in serum [4].  
 
Applications: 
Oral and systemic diseases may affect salivary glands directly or 
indirectly, and may influence the quantity of saliva that is produced, as 
well as the composition of the fluid [5]. These phenomena have significant 
impact in biomarker discovery for disease by utilizing proteomic 
methodologies. A schematic diagram regarding the rationale for human 
salivary proteomics has been presented in Figure 1. 
 
Oral diseases biomarker discovery Salivary proteomics has been 
extensively used for oral diseases biomarker discovery, such as oral cancer 
and Sjögren’s syndrome. Recently, 5 protein biomarkers (Table 1 see 
Supplementary material) have been discovered by 2-DE/MS and 
validated by immunoassays for oral cancer detection [6]. As for primary 
Sjögren’s syndrome, dozens of salivary proteins were found to be down-
regulated or up-regulated in patients when comparing with matched 
healthy control subjects (Table 1 see Supplementary material). These 
proteins reflected the damage of glandular cells and inflammation of the 
oral cavity system in primary Sjögren’s syndrome [7]. 
 
Systematic diseases biomarker discovery Salivary proteomics has also been 
used for systematic diseases biomarker discovery, for example breast 
cancer. The soluble fragment of the c-erbB-2 oncogene was found to be 
significantly higher in saliva collected from patients with breast cancer 
compared to patients with benign tumors and healthy controls. A pilot 
study has indicated that the saliva test for this oncogene is sensitive, 
reliable, and potentially useful in initial detection of and/or follow-up 
screening for breast cancer [8]. Efforts are being made to apply salivary 
proteomics for disease-specific biomarker discovery, such as lung, gastric 
and pancreatic cancer 
 
Challenges: 
Although there is increasing interest in salivary proteome analysis, there 
are still some bottlenecks for salivary proteomic biomarker discovery. 
First, there are some high abundant proteins in saliva, such as amylase, 
albumin, and immunoglobulins, which become the hurdles for the 
detection and quantitation of low abundant proteins. Depletion of these 
interfering proteins prior to definitive analyses should improve the 
resolution and sensitivity of salivary proteome analysis [1]. Second, high 
throughput and quantitative validation methods are urgently needed for the 
confirmation of potential biomarkers that lack available antibodies. The 
development of new technologies will accelerate the biomarker research in 
saliva. Third, and probably not the least, the mechanism behind the disease 
biomarker distribution in saliva should be clarified for further clinical 
screening and detection. A recent study has shown that biomarkers can be 
secreted from lung cancer tumor to mouse saliva [9], which suggests that 
the salivary glands may be regulated by mediators released from remote 
tumors.  
 
Conclusion: 
The proteomes in saliva have been characterized by different proteomic 
technologies, including qualitative and quantitative methods. Based on 
these platforms, salivary proteomic biomarker discovery has been carried 
out in selective oral and systematic diseases. Most importantly, when a 
saliva test could be easily conducted in clinic for early detection of 
diseases, the life quality of patients will be greatly improved. Although 
there are technical and mechanistic challenges, one can anticipate that the 
demands for clinical applications will be the great impetus for the salivary 
proteomics development.   
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Supplementary material:  
 
Table 1: Found salivary proteomic biomarkers for different diseases. 
Disease Typical  Biomarkers  Reference 
Oral Cancer  M2BP, MRP14, CD59, Profilin, Catalase  [6] 
 
Sjögren’s 
Syndrome 
Carbonic anhydrase VI, Polymeric Ig receptor, Lysozyme C, Prolactin-inducible protein, Von Ebner’s gland 
protein, Cystatin C, Cystatin SN, Cystatin D, Cystatin S, Cystatin SA, Calgranulin A, Calgranulin B, Psoriasin, 
Hemoglobin α1-globin chain, Hemoglobin β –chain, Fatty acid binding protein, IGHG1 protein, Ig γ1-chain C-
region, IGHM protein, α –enolase, Salivaryα-amylase, Fructose-bisphosphate aldolase A, Carbonic anhydrase 
I, Carbonic anhydrase II, Caspase 14, Ig κ1-chain C-region, β2-microglobulin, Actin, Serum albumin   
 
[7] 
Breast Cancer  c-erbB-2  [8] 
 
 